c-Rel依赖性Chk2信号调控DNA损伤反应限制肝癌发生
研究探讨c-Rel在肝细胞癌(HCC)中的作用。组织学和转录研究证实HCC患者表达c-Rel,低c-Rel表达与肿瘤细胞增殖增加、突变负荷升高及晚期疾病相关。全局和上皮特异性c-Rel敲除小鼠在N-二乙基亚硝胺损伤后30周比野生型对照发生更多肿瘤、增殖率更高、DNA损伤增加。c-Rel抑制作为辅助治疗增强DNA损伤剂的疗效并减少HCC生长。
要点
- 低c-Rel表达与HCC患者肿瘤细胞增殖增加、突变负荷升高及晚期疾病相关。
- c-Rel敲除小鼠在N-二乙基亚硝胺损伤后30周比野生型对照发生更多肿瘤、增殖率更高、DNA损伤增加。
- c-Rel抑制剂IT-603联合多柔比星在原位HCC模型中比单用多柔比星更有效。
核心结论
- 肝细胞c-Rel信号限制基因毒性损伤及后续HCC负荷。
- 抑制c-Rel作为辅助治疗增加DNA损伤剂的疗效并减少HCC生长。
研究设计与样本
- 研究采用人HCC组织学与转录分析、全局(Rel-/-)和上皮特异性(RelAlb)c-Rel敲除小鼠在N-二乙基亚硝胺损伤后30周的体内实验、体外原代肝细胞实验及原位HCC模型治疗实验。
主要发现
- 人HCC中低c-Rel表达与肿瘤细胞增殖增加和突变负荷升高相关,并与晚期疾病相关。
- N-二乙基亚硝胺损伤后30周,全局和上皮特异性c-Rel敲除小鼠比野生型对照发生更多肿瘤,增殖率更高,DNA损伤增加。
- 肿瘤建立后删除肝细胞c-Rel时肿瘤负荷相当,提示c-Rel信号重要于预防基因毒性损伤后HCC起始而非HCC进展。
- 体外Rel-/-肝细胞比野生型对照更易受基因毒性损伤,且基因毒性损伤后ATM-CHK2 DNA损伤反应通路蛋白在Rel-/-肝细胞中受抑制。
- 原位HCC模型中多柔比星联合IT-603(c-Rel抑制剂)比单用多柔比星更有效。
临床怎么用
- 原文结论认为抑制c-Rel作为辅助治疗可增加DNA损伤剂的疗效并减少HCC生长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. The NF-κB transcription factor family subunit c-Rel is typically protumorigenic; however, it has recently been reported as a tumor suppressor. Here, we investigated the role of c-Rel in HCC. APPROACH AND RESULTS: Histological and transcriptional studies confirmed expression of c-Rel in human patients with HCC, but low c-Rel expression correlated with increased tumor cell proliferation and mutational burden and was associated with advanced disease. In vivo , global ( Rel-/- ) and epithelial specific ( RelAlb ) c-Rel knockout mice develop more tumors, with a higher proliferative rate and increased DNA damage, than wild-type (WT) controls 30 weeks after N-diethylnitrosamine injury. However, tumor burden was comparable when c-Rel was deleted in hepatocytes once tumors were established, suggesting c-Rel signaling is important for preventing HCC initiation after genotoxic injury, rather than for HCC progression. In vitro , Rel-/- hepatocytes were more susceptible to genotoxic injury than WT controls. ATM-CHK2 DNA damage response pathway proteins were suppressed in Rel-/- hepatocytes following genotoxic injury, suggesting that c-Rel is required for effective DNA repair. To determine if c-Rel inhibition sensitizes cancer cells to chemotherapy, by preventing repair of chemotherapy-induced DNA damage, thus increasing tumor cell death, we administered single or combination doxorubicin and IT-603 (c-Rel inhibitor) therapy in an orthotopic HCC model. Indeed, combination therapy was more efficacious than doxorubicin alone. CONCLUSION: Hepatocyte c-Rel signaling limits genotoxic injury and subsequent HCC burden. Inhibiting c-Rel as an adjuvant therapy increased the effectiveness of DNA damaging agents and reduced HCC growth.
引用
- Leslie J, Hunter JE, Collins A, et al. c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis. Hepatology. 2023. PMID: 36089330. doi:10.1002/hep.32781
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。